"The Bill" seems to focus most of its cost efforts with teeth on the public sector payor, Medicare. There are other efforts without teeth, recommendations and prototyping.
Will a 17% tail wag this dog?
You make the call. Even if it doesn't, cost leadership has its knock-on advantages, now and later.
I read things about changing compensation models to reward those providers with superior quality-for-cost. Weighty, thoughtful people make this recommendation. Still, I worry that 'quality' is something that is hard to measure, objectively.
chart
Wednesday, December 9, 2009
Bending the Cost Curve
